These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24784220)

  • 21. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
    Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
    Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role and pharmacological properties of P2Y12 receptor in cancer and cancer pain.
    Hu JL; Zhang WJ
    Biomed Pharmacother; 2023 Jan; 157():113927. PubMed ID: 36462316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration.
    Ohsawa K; Sanagi T; Nakamura Y; Suzuki E; Inoue K; Kohsaka S
    J Neurochem; 2012 Apr; 121(2):217-27. PubMed ID: 22335470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional interaction between purinergic receptors: effect of ligands for A2A and P2Y12 receptors on P2Y1 receptor function.
    Suzuki T; Obara Y; Moriya T; Nakata H; Nakahata N
    FEBS Lett; 2011 Dec; 585(24):3978-84. PubMed ID: 22079667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2.
    Scavone M; Femia EA; Caroppo V; Cattaneo M
    Eur Heart J; 2016 Nov; 37(44):3347-3356. PubMed ID: 26516174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2Y
    Vargas P; Scheffel TB; Diz FM; Rockenbach L; Grave N; Cappellari AR; Kist LW; Bogo MR; Thomé MP; Leal GF; de Fraga Dias A; Figueiró F; Filippi-Chiela EC; Lenz G; Morrone FB
    Purinergic Signal; 2022 Dec; 18(4):481-494. PubMed ID: 35939198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.
    Cooper CL; Morris AJ; Harden TK
    J Biol Chem; 1989 Apr; 264(11):6202-6. PubMed ID: 2495280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-independent.
    Isfort K; Ebert F; Bornhorst J; Sargin S; Kardakaris R; Pasparakis M; Bähler M; Schwerdtle T; Schwab A; Hanley PJ
    J Biol Chem; 2011 Dec; 286(52):44776-87. PubMed ID: 22057273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited dysfunctional platelet P2Y
    Lecchi A; Femia EA; Paoletta S; Dupuis A; Ohlmann P; Gachet C; Jacobson KA; Machura K; Podda GM; Zieger B; Cattaneo M
    Hamostaseologie; 2016 Nov; 36(4):279-283. PubMed ID: 27487748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y
    Li Y; Yin C; Liu P; Li D; Lin J
    Sci Rep; 2017 Oct; 7(1):13764. PubMed ID: 29062134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [(35)S]GTPgammaS autoradiography reveals a wide distribution of G(i/o)-linked ADP receptors in the nervous system: close similarities with the platelet P2Y(ADP) receptor.
    Laitinen JT; Uri A; Raidaru G; Miettinen R
    J Neurochem; 2001 Apr; 77(2):505-18. PubMed ID: 11299313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
    Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
    Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposite modulation of astroglial proliferation by adenosine 5'-O-(2-thio)-diphosphate and 2-methylthioadenosine-5'-diphosphate: mechanisms involved.
    Quintas C; Fraga S; Gonçalves J; Queiroz G
    Neuroscience; 2011 May; 182():32-42. PubMed ID: 21419195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hetero-oligomerization and Functional Interaction between Purinergic Receptors Expressed in Platelets to Regulate Platelet Shape Change].
    Suzuki T
    Yakugaku Zasshi; 2015; 135(12):1335-40. PubMed ID: 26632148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y
    Zhou S; Fang D; Tan S; Lin W; Wu W; Zheng K
    J Biomol Struct Dyn; 2017 Oct; 35(13):2938-2965. PubMed ID: 27634290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
    Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
    Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.